Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01FDL
|
|||
| Former ID |
DIB011120
|
|||
| Drug Name |
Dabelotine
|
|||
| Synonyms |
Dabelotine mesilate; S-12024; S-12024-2
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 3 | [1] | |
| Company |
Servier
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H22N2O2
|
|||
| Canonical SMILES |
CN1CCCC2=C1C(=CC=C2)OCC3CNCCO3
|
|||
| InChI |
1S/C15H22N2O2/c1-17-8-3-5-12-4-2-6-14(15(12)17)19-11-13-10-16-7-9-18-13/h2,4,6,13,16H,3,5,7-11H2,1H3
|
|||
| InChIKey |
VXQWMLATWQSCBE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 118976-38-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Adrenergic receptor (ADR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002175) | |||
| REF 2 | US patent application no. 2007,0049,576, Neurogenesis by muscarinic receptor modulation. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.